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Introduction {#jgh312106-sec-0005}
============

The incidence of colorectal polyps is high in colonoscopy screening, accounting for 25% of lesions, mostly benign.[1](#jgh312106-bib-0001){ref-type="ref"} Colorectal cancer is the third most common tumor worldwide and the fourth cause of morbidity from tumors.[2](#jgh312106-bib-0002){ref-type="ref"} The early detection and removal of polyps lead to a marked reduction in the incidence of colorectal cancer.[3](#jgh312106-bib-0003){ref-type="ref"}, [4](#jgh312106-bib-0004){ref-type="ref"} Complications following polypectomy have significantly reduced with the advancement of the submucosal injection technique,[5](#jgh312106-bib-0005){ref-type="ref"}, [6](#jgh312106-bib-0006){ref-type="ref"}, [7](#jgh312106-bib-0007){ref-type="ref"} but the potential for iatrogenic injury during polypectomy still exists.[5](#jgh312106-bib-0005){ref-type="ref"} The primary complications are hemorrhage and perforation,[8](#jgh312106-bib-0008){ref-type="ref"} and hemorrhage includes immediate and delayed postoperative bleeding. The incidence rate of the delayed type is 0.4--1.1%,[9](#jgh312106-bib-0009){ref-type="ref"}, [10](#jgh312106-bib-0010){ref-type="ref"} with evidently more blood loss compared with the immediate type and delayed management, endangering life. Hence, the prudence of clinicians should never be undermined.[11](#jgh312106-bib-0011){ref-type="ref"} Therefore, the identification of risk factors for delayed postpolypectomy hemorrhage is essential for the reduction of risks of complications and bleeding. A spectrum of studies exists regarding postoperative hemorrhage, but with contradictory results. The relatively unequivocal awareness is the close correlation of polyp size with hemorrhage. More controversy of perceptions lies in the correlation with other factors, including polyp location, pathology, operative modality, concurrent diseases, and preoperative anticoagulation medications. Bowel preparation and surgeon experience are less referred.

The causal factors for bleeding include concurrent lesions, bowel preparation, location and size of polyps, operative modality, and operation clinicians. This study analyzed the risk factors from the aforementioned multiple perspectives for delayed postpolypectomy hemorrhage.

Methods {#jgh312106-sec-0006}
=======

This study was a retrospective cohort study analyzing patients who underwent colonoscopic polypectomy at the Department of Gastroenterology and Hepatology, Shanghai Tenth People\'s Hospital of Tongji University, China, between January and December 2015. Delayed hemorrhage was defined as more than one occurrence of overt bleeding per anus, including melena or hematochezia, 6 h after operation. Each delayed hemorrhage had undergone a therapeutic colonoscopy. The inclusion criteria were patients who underwent colonoscopic polypectomy at the age of 18--80 years, excluding patients with familial adenomatous polyps, polyps combined with inflammatory bowel disease, or a history of colorectal surgery. At least 1‐week cessation of anticoagulation medicines, such as aspirin, Plavix, and warfarin, was instructed for all patients, and not even one patient took the specific medicine at the interval of 1 week before operation. Bowel preparation was recorded by two doctors with more than 5 years of specific practice according to Ottawa Bowel Preparation Scale.[12](#jgh312106-bib-0012){ref-type="ref"} Patient\'s information, including age, gender, concurrent diseases, bowel preparation, location, size and number of polyps, operative modality, pathology, and operation practitioner, was collected. Polyp size was assessed by an endoscopist and classified into four grades: \<1 cm, 1--2 cm, 2--3 cm, and ≥3 cm. Polyp location was classified as rectum, left semicolon distal to the splenic flexure, and right semicolon proximal to the splenic flexure. Operative modalities comprised biopsy forceps polypectomy, argon plasma coagulation (APC), endoscopic mucosal resection (EMR), and endoscopic submucosal dissection (ESD). Pathologically, polyps were divided into three types: hyperplastic and inflammatory polyps, adenomatous polyps (tubular adenoma, villous adenoma, and villous tubular adenoma), and serrated adenoma. Surgeons were classified into three grades based on practice experience: 5--10 years, 10--15 years, and more than 15 years. This retrospective study had been approved by the ethnic committee of Shanghai Tenth People\'s Hospital of Tongji University. All data were anonymized and deidentified.

Statistical analysis {#jgh312106-sec-0007}
--------------------

All data were analyzed using SPSS version 21 (SPSS, Chicago, IL, USA). Enumeration data were expressed in percentage. Regarding measurement data, normal distribution was expressed in mean ± standard deviation, whereas nonnormal distribution was expressed in median (range). Continuous variables were statistically analyzed using the Student *t* test, and categorical variables were compared using the *χ* ^2^ test. The correlation was initially screened among all variables, followed by the binary logistic regression analysis of definitely correlated variables, and the odds ratio (OR) and 95% confidence interval (CI) were calculated for others after defining the first one as a reference value of 1. A double‐tailed *P* value \<0.05 was considered statistically significant.

Results {#jgh312106-sec-0008}
=======

Incidence rate of postpolypectomy hemorrhage {#jgh312106-sec-0009}
--------------------------------------------

A total of 1962 polyps were detected in 709 patients; hemorrhage occurred in 41 cases, with an incidence rate of 5.8%. The bleeding interval was 1.85 ± 1.05 days after operation. Concurrent disease---diabetes, coronary heart disease, or cerebrovascular accident---was not correlated with delayed postpolypectomy hemorrhage, whereas hypertension patients were more susceptible to postoperative hemorrhage, as shown in Table [1](#jgh312106-tbl-0001){ref-type="table"}.

###### 

General information and complications of patients with delayed postpolypectomy hemorrhage.

                              Uneventful (*n* = 668)   Hemorrhage (*n* = 41)  *P*
  -------------------------- ------------------------ ----------------------- -------
  Age (mean ± SD)                 61.00 ± 9.376           62.71 ± 11.237      0.263
  Gender (%)                                                                  0.044
  Male                            435/668 (65.1)           33/41 (80.0)       --
  Female                          233/668 (34.9)            8/41 (20.0)       --
  Complications                                                               
  High blood pressure               285 (42.7)               25 (61.0)        0.022
  Diabetes                          100 (15.0)                4 (9.8)         0.360
  Coronary heart disease             50 (7.5)                5 (12.2)         0.274
  Cerebrovascular accident           34 (5.1)                  2 (5)          0.952

Risk factors for delayed postpolypectomy hemorrhage {#jgh312106-sec-0010}
---------------------------------------------------

The risk factors for delayed postpolypectomy hemorrhage included polyp size and operative modality. No obvious correlation of delayed postpolypectomy hemorrhage was found with the pathological type, polyp location, bowel preparation, or operative experience. OR was 4.535 (95% CI, 2.331--8.823; *P* \< 0.001) for 1--2‐cm polyps, 4.008 (95% CI, 0.904--17.776; *P* = 0.068) for 2--3‐cm polyps, and 22.407 (95% CI, 5.783--86.812; *P* \< 0.001) for ≥3‐cm polyps compared with \<1 cm polyps. In terms of operative modality, OR was 9.128 (95% CI, 3.548--23.486; *P* \< 0.001) for EMR and 31.257 (95% CI, 7.009--139.395; *P* \< 0.001) for ESD and 0.000 (*P* = 0.999) for forceps polypectomy compared with APC. Detailed information is listed in Tables [2](#jgh312106-tbl-0002){ref-type="table"} and [3](#jgh312106-tbl-0003){ref-type="table"}.

###### 

Analysis of risk factors for delayed postpolypectomy hemorrhage.

                                      Uneventful (*n* = 1921)    Hemorrhage (*n* = 41)  *P* (two tailed)
  ----------------------------------- ------------------------- ----------------------- ------------------
  Polyp location (%)                                                                    0.855
  Colon                               345/1921 (18.0)                 7/41 (17.1)       
  Left semicolon                      998/1921 (52.0)                20/41 (48.8)       
  Right semicolon                     578/1921 (30.0)                14/41 (34.1)       
  Polyp size (%)                                                                        \<0.001
  \<1 cm                              1561/1921 (81.3)               19/41 (46.3)       
  1 cm ≤ polyp \< 2 cm                308/1921 (16.0)                17/41 (41.5)       
  2 cm ≤ polyp \< 3 cm                41/1921 (2.1)                   2/41 (4.9)        
  ≥3 cm                               11/1921 (0.6)                   3/41 (7.3)        
  Operative modality (%)                                                                \<0.001
  APC                                 1094/1921 (56.9)                5/41 (12.2)       
  EMR                                 791/1921 (41.2)                33/41 (80.5)       
  ESD                                 20/1921 (1.1)                   3/41 (7.3)        
  Forceps polypectomy                 16/1921 (0.8)                    0/41 (0)         
  Pathology (%)                                                                         \<0.001
  Hyperplastic + inflammatory polyp   202/1921 (10.5)                 6/41 (14.6)       
  Tubular adenoma                     302/1921 (15.8)                16/41 (39.0)       
  Villous adenoma                     18/1921 (0.9)                   3/41 (7.3)        
  Villous tubular adenoma             106/1921 (5.5)                  7/41 (17.1)       
  Malignant tumor                     31/1921 (1.6)                   1/41 (2.4)        
  Serrated adenoma                    24/1921 (1.2)                   1/41 (2.4)        
  Juvenile polyp                      0 (0)                           1/41 (2.4)        
  Leiomyoma                           0 (0)                           1/41 (2.4)        
  Carcinoid                           1/1921 (0.05)                      0 (0)          
  Fibro‐epithelial hyperplasia        2/1921 (0.1)                       0 (0)          
  No pathology                        1233/1921 (64.2)                1/41 (12.2)       
  Bowel preparation (%)                                                                 0.323
  Excellent                           462/1921 (24.0)                11/41 (26.8)       
  Good                                637/1921 (33.2)                 5/41 (22.0)       
  Fair                                724/1921 (37.7)                17/41 (41.5)       
  Poor                                98/1921 (5.1)                   4/41 (9.7)        
  Specific operation experience (%)                                                     0.505
  5--10 years                         22/1921 (1.1)                        0            
  10--15 years                        787/1921 (41.0)                14/41 (34.1)       
  \>15 years                          1112/1921 (57.9)               27/41 (65.9)       

APC, argon plasma coagulation; EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissection.

###### 

Regression analysis of risk factors for delayed postpolypectomy hemorrhage.

                                     Odds ratio  95% confidence interval   *P*
  --------------------------------- ------------ ------------------------- ---------
  Pathology                                                                
  Hyperplastic/inflammatory polyp        1       --                        --
  Adenomatous polyp                    1.879     0.756--4.669              0.174
  Serrated adenoma                     1.403     0.162--12.150             0.759
  malignant neoplasm                   1.086     0.126--9.328              0.940
  Polyp size                                                               
  \<1 cm                                 1       --                        --
  1--2 cm                              4.535     2.331--8.823              \<0.001
  2--3 cm                              4.008     0.904--17.776             0.068
  \>3 cm                               22.407    5.783--86.812             \<0.001
  Operative modality                                                       
  APC                                    1       --                        --
  EMR                                  9.128     3.548--23.486             \<0.001
  ESD                                  31.257    7.009--139.395            \<0.001
  Forceps polypectomy                    0       ND                        0.999

APC, argon plasma coagulation; EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissection.

Discussion {#jgh312106-sec-0011}
==========

This study analyzed correlation factors for postpolypectomy hemorrhage. Delayed postpolypectomy hemorrhage occurred within the interval of 6 h to 4 days, at a mean time of 1.85 ± 1.05 days, which was similar to the findings of Kim Hee.[13](#jgh312106-bib-0013){ref-type="ref"}, [14](#jgh312106-bib-0014){ref-type="ref"} Therefore, more caution was needed against delayed hemorrhage 1--3 days after operation. Other studies reported the incidence of delayed hemorrhage within postoperative 6 h to 17 days.[15](#jgh312106-bib-0015){ref-type="ref"} Therefore, postoperative surveillance for hemorrhage should be prolonged to avoid serious outcomes.

Referring to prior literature, the present study also displayed polyp size as a conspicuous risk factor. Min and colleagues discovered that the incidence rate was 2.6‐fold higher for polyps larger than 1 cm than for smaller polyps.[16](#jgh312106-bib-0016){ref-type="ref"} Another study reported that every 1‐mm increase in polyp size increased the incidence rate by 11.6%.[17](#jgh312106-bib-0017){ref-type="ref"} Previous studies did not analyze the polyp size of various ranges but assessed the mean size. In contrast, the present study achieved a more meaningful conclusion by the classification of polyp size. Nonetheless, the limited number of \>3‐cm polyps could give rise to bias.

In terms of operative modality, Zhang et al. found that EMR or endoscopic piecemeal mucosal resection was more susceptible to hemorrhage compared with APC or biopsy forceps polypectomy, but without statistical significance.[15](#jgh312106-bib-0015){ref-type="ref"} The present study demonstrated a 9.128‐fold incidence rate of hemorrhage in EMR and 31.257‐fold susceptibility to hemorrhage in ESD with statistical significance. The difference could be caused by the exclusion of ESD from the comparisons in Zhang\'s study.

Regarding pathology, Watabe et al. believed that no difference in postoperative hemorrhage existed between adenoma and adenocarcinoma, with the conclusion derived from 37 cases.[18](#jgh312106-bib-0018){ref-type="ref"} In contrast, Zhang and colleagues found a close correlation between pathology and postoperative hemorrhage (4.3‐ and 3.3‐fold), respectively, in juvenile polyposis and Peutz‐Jeghers syndrome compared with inflammatory/hyperplastic polyps.[15](#jgh312106-bib-0015){ref-type="ref"} In the present study, no significant increase is found in hemorrhage in adenomatous polyps.

Some studies suggested a correlation between polyp location and postpolypectomy hemorrhage. The right semicolon was more susceptible to postoperative hemorrhage compared with the left semicolon.[19](#jgh312106-bib-0019){ref-type="ref"}, [20](#jgh312106-bib-0020){ref-type="ref"} The present study detected no conspicuous correlation between them, which could be related to higher incidences of polyps in the left semicolon of Chinese populations but nearly equal incidence in the left and right semicolon of Western populations.[21](#jgh312106-bib-0021){ref-type="ref"} In the present study, 17.9% of polyps were located in the rectum, 51.9% in the left semicolon, and 30.2% in the right semicolon.

This study had certain limitations. First, it was a single‐center retrospective analysis, and data of only 1 year is not comprehensive. Second, the number of polyps ≥3 cm in size was inadequate, and hence, the results could interfere with the precision of the conclusion. Meanwhile, the assessment of bowel preparation was literally subjective, leading to potential bias on evaluation and hence a statistical error.

In summary, this study demonstrated the risk factors for postpolypectomy hemorrhage, including polyp size and operative modality. For polyps \>1 cm in size, the operative modality of ESD resulted in a higher incidence of hemorrhage. More clinical prudence should be taken in this regard.
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